Skip to content

Effect of chitosan supplement on serum lipid and body composition in overweight or obese Asian-women.

Effects of chitosan supplements on serum lipid and body composition in overweight or obese Asian-women: A Randomized, double-blind, placebo-controlled trial.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230606001
Enrollment
65
Registered
2023-06-06
Start date
2022-01-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Thai women who are overweight or obese. Thai women, overweight, obesity

Interventions

Rice flour ,Chitosan supplement 1.5 g per day,Chitosan supplement 3 g per day
Group1,Group 2,Group 3

Sponsors

Siriraj Medical Research center, Siriraj Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1) Thai women with overweight or obese women with a BMI less or equal to 23 kg/m2, 2) waist less or equal to 80 cm, 3) age between 30 to 59 years old, 4) total cholesterol level less than 200 mg/dL or LDL-C level less than 130 mg/dL, and 5) can take food photos and use the LINE application to send the information. All participants were invited to collect blood sample to analyse the level of lipid profiles that passed the criteria.

Exclusion criteria

Exclusion criteria: 1) had a history of metabolic syndrome, hepatic, renal, autoimmune, gastrointestinal, or neurological disease; 2) current or recent consumed supplements, OTC (over-the-counter) products, and/or pharmaceutical agents that might influence the outcome of this study (Orlistat); 3) current or recent having a history of eating disorders, bipolar disorder, or severe depression; 4) pregnant or lactating woman; 5) allergies or intolerance to crustaceans and/or seafood products; 6) vegetarian; 7) COVID-19 patient; 8) recovered from COVID-19 less than 3 months; and 9) individuals judged to be unlikely to comply with study treatment and follow-up procedures.

Design outcomes

Primary

MeasureTime frame
Lipid levels at 2 months after end of the intervention F-tests for pairwise comparisons and two-way ANOVA test for repeated measures

Secondary

MeasureTime frame
Body compositions at 2 months after end of the intervention F-tests for pairwise comparisons and two-way ANOVA test for repeated measures

Countries

Thailand

Contacts

Public ContactKitti Sranacharoenpong

Mahidol University

kitti.sra@mahidol.ac.th0818394069

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026